Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial
Titel:
Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial
Auteur:
Bartlett, J.M.S. Sgroi, D.C. Treuner, K. Zhang, Y. Ahmed, I. Piper, T. Salunga, R. Brachtel, E.F. Pirrie, S.J. Schnabel, C.A. Rea, D.W.